rxLicense

License Required

wishlistAlt
Otrexup Methotrexate Auto-Injector for RA, pJIA & Psoriasis
Otrexup Methotrexate Auto-Injector for RA, pJIA & Psoriasis
Compare
View Alternative

Otrexup™ Methotrexate 15 mg / 0.4 mL Preservative Free Injection - Auto-Injector for Rheumatoid Arthritis, pJIA & Psoriasis

54436001504 | USAMP#48446898

container type

Prefilled Auto-Injector

dosage form

Injection

strength

15 mg / 0.4 mL
20 mg / 0.4 mL

Product Description

  • Otrexup™ offers a convenient, single-dose auto-injector design for precise methotrexate delivery, aimed at improving patient compliance and outcomes.
  • Indicated for adults with severe, active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis (pJIA), and adults with severe, resistant, disabling psoriasis, ensuring a broad application spectrum.
  • Specifically formulated without preservatives to minimize potential side effects, enhancing patient safety.
  • Not recommended for cancer treatment or for children with psoriasis, prioritizing targeted therapeutic use.
  • Each auto-injector ensures a fixed volume of 0.4 mL for consistent dosing.

Product Specification

Manufacturer SKU

54436001504

NDC Code

54436001504

Manufacturer

Antares Pharma Inc

Brand

Otrexup™

USAMP SKU

USAMP#48446898

Application

Antineoplastic Agent

UNSPSC Code

51111610

Alternate Manufacturer Number

2055259

Country Of Origin

Unknown

Product Dating

USAMP Acceptable Dating: we will ship >= 90 days

Quantity

4 Devices

Strength

15 mg / 0.4 mL

Container Type

Prefilled Auto-Injector

Type

Subcutaneous

Dosage Form

Injection

Generic Drug Code

35428

Generic Drug Name

Methotrexate, Preservative Free